Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.

Mitoxantrone is one of the few drugs approved for the treatment of progressive multiple sclerosis (MS). However, the prolonged use of this potent immunosuppressive agent is limited by the appearance of severe side effects. Apart from its general cytotoxic effect, the mode of action of mitoxantrone o...

Full description

Saved in:
Bibliographic Details
Main Authors: Coralie Chanvillard, Jason M Millward, Marta Lozano, Isabell Hamann, Friedemann Paul, Frauke Zipp, Jan Dörr, Carmen Infante-Duarte
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2012
Subjects:
R
Q
Online Access:https://doaj.org/article/c55664edcf084ee19141d3c0f2cddf6c
Tags: Add Tag
No Tags, Be the first to tag this record!